SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-15-013108
Filing Date
2015-06-30
Accepted
2015-06-30 16:06:52
Documents
13
Period of Report
2015-06-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ipxl20150629_8k.htm 8-K 57013
2 EXHIBIT 4.1 ex4-1.htm EX-4.1 825141
3 EXHIBIT 10.1 ex10-1.htm EX-10.1 278837
4 EXHIBIT 10.2 ex10-2.htm EX-10.2 271193
5 EXHIBIT 10.3 ex10-3.htm EX-10.3 280225
6 EXHIBIT 10.4 ex10-4.htm EX-10.4 273090
7 rbc.jpg GRAPHIC 4951
8 image7.jpg GRAPHIC 3577
9 image5.jpg GRAPHIC 2533
10 image4.jpg GRAPHIC 3087
11 image3.jpg GRAPHIC 2940
12 image2.jpg GRAPHIC 2734
13 image.jpg GRAPHIC 2313
  Complete submission text file 0001437749-15-013108.txt   2018248
Mailing Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544 510-240-6000
IMPAX LABORATORIES INC (Filer) CIK: 0001003642 (see all company filings)

IRS No.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34263 | Film No.: 15961499
SIC: 2834 Pharmaceutical Preparations